0001192482-15-000369.txt : 20150810 0001192482-15-000369.hdr.sgml : 20150810 20150810150519 ACCESSION NUMBER: 0001192482-15-000369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150810 FILED AS OF DATE: 20150810 DATE AS OF CHANGE: 20150810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001621443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260389433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 BUSINESS PHONE: 484-581-7505 MAIL ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 FORMER COMPANY: FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc. DATE OF NAME CHANGE: 20141003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAPP MICHAEL CENTRAL INDEX KEY: 0001405685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37526 FILM NUMBER: 151040393 MAIL ADDRESS: STREET 1: 712 FIFTH AVENUE STREET 2: 49TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-10 0001621443 Zynerba Pharmaceuticals, Inc. ZYNE 0001405685 RAPP MICHAEL 712 FIFTH AVE, 22ND FLOOR NEW YORK NY 10019 0 0 1 0 Common Stock 2015-08-10 4 C 0 567505 A 1263648 D Series 1 Convertible Preferred Stock 2015-08-10 4 C 0 1066911 0 D Common Stock 567505 0 D The Series 1 Convertible Preferred Stock converted into Zynerba Pharmaceuticals, Inc. common stock on a 1.88-for-1 basis. The Series 1 Convertible Preferred Stock had no expiration date. Suzanne M. Hanlon, Attorney-in-Fact 2015-08-10